Examination of serum amyloid A protein in kidney transplant patients.
Fukuda
Y
Y
Department of General Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Hoshino
S
S
Tanaka
I
I
Yoneya
T
T
Takeshita
T
T
Sumimoto
R
R
Kanbe
M
M
D001053:Apolipoproteins / Q000032:analysis*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D003404:Creatinine / Q000097:blood; D003586:Cytomegalovirus Infections / Q000097:blood / Q000175:diagnosis; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011498:Protein Precursors / Q000097:blood; D012016:Reference Values; D000685:Serum Amyloid A Protein / Q000032:analysis*; D013997:Time Factors
D001053:Apolipoproteins; D015415:Biomarkers; D011498:Protein Precursors; D000685:Serum Amyloid A Protein; D002097:C-Reactive Protein; D003404:Creatinine